May 01, 2019 Rainier Therapeutics Announces Appointment of Gary Christianson as Chief Technical Officer
May 01, 2019 Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update
April 30, 2019 Pulmonx Announces That HUMANA Has Issued a Positive Coverage Policy for the Zephyr Valve, a Less Invasive Treatment Option for Severe Emphysema (COPD)
April 25, 2019 Rainier Therapeutics Announces Vofatamab Data Accepted for Presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
April 25, 2019 Strongbridge Biopharma plc Announces Presentation of New Secondary Endpoint Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2019 American Association of Clinical Endocrinologists Ann
April 25, 2019 BONESUPPORT HOLDING AB (publ) – Q1 2019 Interim Report – invitation to conference call and webcast
April 25, 2019 GenSight Biologics announces presentation of 72-week data from the REVERSE & RESCUE Phase III trials of GS010 at the Annual Meeting of ARVO
April 24, 2019 Oncopeptides provides new guidance on the patient recruitment in the OCEAN study and a clinical program update in a webcast at 10:00 (CET)